The effectiveness of the speech enhancer(TM)

Journal of Medical Speech-Language Pathology

Volumn 7, Issue 4, 1999, Pages 315-322

  Cariski, Denise ^a   Rosenbek, Jay ^a  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEVICE; DYSARTHRIA; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SPEECH INTELLIGIBILITY; SPEECH THERAPY;

EID: 0032760565     PISSN: 10651438     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adams, S. G. (1997). Hypokinetic dysarthria in Parkinson's disease. In M. R. McNeil (Ed.), Clinical management of sensorimotor speech disorders (pp. 261-285). New York: Thieme.
2. Dagenais, P. A., Southwood, M. H., & Lee, T. L. (1998). Rate reduction methods for improving speech intelligibility of dysarthric speakers with Parkinson's disease. Journal of Medical Speech-Language Pathology, 6, 143-157.
3. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969a). Clusters of deviant speech dimensions in the dysarthrias. Journal of Speech and Hearing Research, 12, 462-469.
4. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969b). Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research, 12, 246-269.
5. Dufiy, J. R. (1995). Motor speech disorders: Substrates, differential diagnosis, and management. St. Louis, MO: Mosby-Year Book.
6. Ebmeier, K P., Calder, J. R., Crawford, J. R., Stewart, L., Cochrane, R. H. B., & Besson, J. A. O. (1991). Dementia in idiopathic Parkinson's disease: Prevalence and relationship with symptoms and signs of parkinsonism. Psychological Medicine, 21, 69-76.
7. Greene, M. C. L., & Watson, B. W. (1968). The value of speech amplification in Parkinson's disease patients. Folia Phoniatrica, 20, 250-257.
8. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression, and mortality. Neurology, 17, 427.
9. Levin, B. E., Tomer, R., & Rey, G. J. (1992). Cognitive impairments in Parkinson's disease. Neurologic Clinics, 10, 471-485.
10. Ramig, L. O., Bonitati, C. M., Lemke, J. H., & Horii, Y. (1994). Voice treatment for patients with Parkinson disease: Development of an approach and preliminary efficacy data. Journal of Medical Speech-Language Pathology, 2, 191-209.
11. Ramig, L. O., Countryman, S., Thompson, L. L., & Horii, Y. (1995). Comparison of two forms of intensive speech treatment for Parkinson's disease. Journal of Speech and Hearing Research, 38, 1232-1251.
12. Rubow, R., & Swift, E. (1985). A microcomputer-based wearable biofeedback device to improve transfer of treatment in parkinsonian dysarthria. Journal of Speech and Hearing Disorders, 50, 178-185.
13. Sarno, M. T. (1968). Speech impairment in Parkinson's disease. Archives of Physical Medicine and Rehabilitation, 49, 269-275.
14. Speech Enhancer™ Electronic Speech Enhancement, Inc., St. Louis, MO.
15. Sullivan, M. D., Brune, P. F., & Beukelman, D. R. (1996). Maintenance of speech changes following group treatment for hypokinetic dysarthria of Parkinson's disease. In D. A. Robin, K. M. Yorkston, & D. R. Beukelman (Eds.), Disorders of motor speech: Assessment, treatment, and clinical characterization (pp. 287-307). Baltimore: Paul H. Brookes.
16. Yorkston, K. M., & Beukelman, D. R. (1981). Assessment of intelligibility of dysarthric speech. Tigard, OR: C. C. Publications, Inc.